Weight loss jabs bring health gains for 75-year-old

A 75-year-old woman reports dramatic health gains from weight loss injections, paralleling questions about access and affordability in public health systems.

Weight loss jabs redefine life at 75

Susan Forgie, 75, from Oswestry, credits Mounjaro injections with a 12-stone weight loss and a drastic improvement in health after years of yo-yo dieting and mounting health issues. She says her mobility has improved, joint pain faded, and cravings for sweets diminished, with her blood pressure medication eventually halted. Her thyroid dose was reduced, and a gym assessment estimated her metabolic age at 59, sixteen years younger than her actual age. The couple spent about £4,600 on the medication over 23 months, which Forgie argues pays for itself through savings on food and takeaways. Her partner Tim, who joined the program, also lost weight. The NHS eligibility for weight loss injections varies by drug and BMI, with ongoing rationing as clinicians evaluate who should receive treatment.

This story highlights how medical advances can rapidly alter a person’s life, even in later years, while exposing cracks in health access. Private clinics offer options that public systems struggle to fund, creating a two-tier dynamic where cost shapes who can benefit. It also raises questions about long-term safety, ongoing costs, and whether weight loss medications should stand alone or be part of broader lifestyle and support programs. As demand grows, policymakers must balance promise with affordability and equity, ensuring that life-changing outcomes do not hinge on money alone.

Highlights

Public health decisions will need to weigh individual success against system-wide costs and fairness.